Skip to main content
. 2001 Aug;75(16):7290–7304. doi: 10.1128/JVI.75.16.7290-7304.2001

TABLE 7.

Viremia after YF/DEN1-4 tetravalent immunization (total dose, 5.4 log10 PFU) in YF-immune and nonimmune monkeys

YF immune Monkey Viremia (log10 PFU/ml) by post-secondary immunization day:
Mean
Serotype isolatede (day[s])
1 2 3 4 5 6 7 8 9 10 11f Peak titerb (SD) Durationc (SD)
Yes BA29 a 2.0 1.4 1.3 (0.9) 1.5 (0.7) 1, 2 (2–3)
V576
V202 0.7 2 (3)
No BF33 1.0 2.5 2.2 1.4 2.4 (0.2) 4.7 (1.5) 2 (1–4)
BF29 2.3 2.5 1.9 2 (2–4), 3 (3)
BJ43 1.4 2.1 2.1 1.4 1.4 2.2 2 (1–4), 4 (10–11)
BD24 1.4 2.6 2.0 1.4 1.4 0.7 2 (3, 4, 6, 9)
BB88 1.0 2.5 2.4 1.9 1.0 1.0 2 (1, 2, 4, 6)
BG30 2.2 2.1 1.7 2 (2–4)
Pd 0.007 0.007
a

—, <0.7 log10 PFU/ml.). 

b

Log10 PFU per milliliter 

c

Days. 

d

Peak titers and duration of viremia in YF-immune group were compared to values from non immune group by t test (JPM version 4.0.2). 

e

Determined by RT-PCR followed by HindIII digestion. 

f

No viremia was detected after this day.